Der var ingen forskel på typen af hændelser behandlingsgrupperne imellem, uanset om patienterne var over eller under 80 år ved inklusion.
4 There were no differences in the nature of adverse events between treatment groups regardless of whether patients were aged below or above 80 at inclusion.